Mckayla Schmitt, MD | |
8100 Northland Dr, Bloomington, MN 55431-4800 | |
(952) 831-8742 | |
Not Available |
Full Name | Mckayla Schmitt |
---|---|
Gender | Female |
Speciality | Sports Medicine |
Experience | 9 Years |
Location | 8100 Northland Dr, Bloomington, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144617366 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Park Nicollet Clinic | 7911819438 | 1529 |
News Archive
Blood tests have been a mainstay of diagnostic medicine since the late 19th century, offering a wealth of information concerning health and disease. Nevertheless, blood derived from the human umbilical cord has yet to be fully mined for its vital health information, according to Rolf Halden, a researcher at Arizona State University's Biodesign Institute.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY), one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.
The Rasmussen Encephalitis (RE) Children's Project, a foundation that supports scientific research to find a cure for this devastating neurological disease, has donated $111,000 to researchers in the departments of neurosurgery and pathology/lab medicine (neuropathology) at Ronald Reagan UCLA Medical Center.
A large-scale single-cell screening endeavor on a wide variety of animals showed that cells targeted by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are most abundant in cats, but are also found in other animals – unveiling a valuable resource for controlling the ongoing disruptive coronavirus disease (COVID-19) pandemic.
Scientists from the Jupiter campus of The Scripps Research Institute (TSRI) have shown a novel way to dramatically raise the potency of drug candidates targeting RNA, resulting in a 2,500-fold improvement in potency and significantly increasing their potential as therapeutic agents.
› Verified 4 days ago
Entity Name | Park Nicollet Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
Blood tests have been a mainstay of diagnostic medicine since the late 19th century, offering a wealth of information concerning health and disease. Nevertheless, blood derived from the human umbilical cord has yet to be fully mined for its vital health information, according to Rolf Halden, a researcher at Arizona State University's Biodesign Institute.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY), one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.
The Rasmussen Encephalitis (RE) Children's Project, a foundation that supports scientific research to find a cure for this devastating neurological disease, has donated $111,000 to researchers in the departments of neurosurgery and pathology/lab medicine (neuropathology) at Ronald Reagan UCLA Medical Center.
A large-scale single-cell screening endeavor on a wide variety of animals showed that cells targeted by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are most abundant in cats, but are also found in other animals – unveiling a valuable resource for controlling the ongoing disruptive coronavirus disease (COVID-19) pandemic.
Scientists from the Jupiter campus of The Scripps Research Institute (TSRI) have shown a novel way to dramatically raise the potency of drug candidates targeting RNA, resulting in a 2,500-fold improvement in potency and significantly increasing their potential as therapeutic agents.
› Verified 4 days ago
Entity Name | Fairview Health Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
Blood tests have been a mainstay of diagnostic medicine since the late 19th century, offering a wealth of information concerning health and disease. Nevertheless, blood derived from the human umbilical cord has yet to be fully mined for its vital health information, according to Rolf Halden, a researcher at Arizona State University's Biodesign Institute.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY), one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.
The Rasmussen Encephalitis (RE) Children's Project, a foundation that supports scientific research to find a cure for this devastating neurological disease, has donated $111,000 to researchers in the departments of neurosurgery and pathology/lab medicine (neuropathology) at Ronald Reagan UCLA Medical Center.
A large-scale single-cell screening endeavor on a wide variety of animals showed that cells targeted by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are most abundant in cats, but are also found in other animals – unveiling a valuable resource for controlling the ongoing disruptive coronavirus disease (COVID-19) pandemic.
Scientists from the Jupiter campus of The Scripps Research Institute (TSRI) have shown a novel way to dramatically raise the potency of drug candidates targeting RNA, resulting in a 2,500-fold improvement in potency and significantly increasing their potential as therapeutic agents.
› Verified 4 days ago
Entity Name | Tria Orthopaedic Center Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518273085 PECOS PAC ID: 3173570561 Enrollment ID: O20110310000999 |
News Archive
Blood tests have been a mainstay of diagnostic medicine since the late 19th century, offering a wealth of information concerning health and disease. Nevertheless, blood derived from the human umbilical cord has yet to be fully mined for its vital health information, according to Rolf Halden, a researcher at Arizona State University's Biodesign Institute.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY), one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.
The Rasmussen Encephalitis (RE) Children's Project, a foundation that supports scientific research to find a cure for this devastating neurological disease, has donated $111,000 to researchers in the departments of neurosurgery and pathology/lab medicine (neuropathology) at Ronald Reagan UCLA Medical Center.
A large-scale single-cell screening endeavor on a wide variety of animals showed that cells targeted by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are most abundant in cats, but are also found in other animals – unveiling a valuable resource for controlling the ongoing disruptive coronavirus disease (COVID-19) pandemic.
Scientists from the Jupiter campus of The Scripps Research Institute (TSRI) have shown a novel way to dramatically raise the potency of drug candidates targeting RNA, resulting in a 2,500-fold improvement in potency and significantly increasing their potential as therapeutic agents.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mckayla Schmitt, MD 8170 33rd Ave S # Ms 21110q, Bloomington, MN 55425-4516 Ph: () - | Mckayla Schmitt, MD 8100 Northland Dr, Bloomington, MN 55431-4800 Ph: (952) 831-8742 |
News Archive
Blood tests have been a mainstay of diagnostic medicine since the late 19th century, offering a wealth of information concerning health and disease. Nevertheless, blood derived from the human umbilical cord has yet to be fully mined for its vital health information, according to Rolf Halden, a researcher at Arizona State University's Biodesign Institute.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY), one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.
The Rasmussen Encephalitis (RE) Children's Project, a foundation that supports scientific research to find a cure for this devastating neurological disease, has donated $111,000 to researchers in the departments of neurosurgery and pathology/lab medicine (neuropathology) at Ronald Reagan UCLA Medical Center.
A large-scale single-cell screening endeavor on a wide variety of animals showed that cells targeted by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are most abundant in cats, but are also found in other animals – unveiling a valuable resource for controlling the ongoing disruptive coronavirus disease (COVID-19) pandemic.
Scientists from the Jupiter campus of The Scripps Research Institute (TSRI) have shown a novel way to dramatically raise the potency of drug candidates targeting RNA, resulting in a 2,500-fold improvement in potency and significantly increasing their potential as therapeutic agents.
› Verified 4 days ago
Dr. Darren Dale Bray, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8600 Nicollet Ave S, Bloomington, MN 55420 Phone: 952-541-2800 | |
Linda Eelkema, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7920 Old Cedar Ave S, Bloomington, MN 55425 Phone: 952-851-1000 Fax: 952-851-1092 | |
Aner Vlodaver, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 600 W 98th St, Bloomington, MN 55420 Phone: 952-885-6150 | |
Sandhya Joshi, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7920 Old Cedar Ave S, Bloomington, MN 55425 Phone: 952-428-1800 | |
Yasmin Jeanne Khan, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5320 Hyland Greens Dr, Bloomington, MN 55437 Phone: 952-993-2400 | |
Dr. Aaron Kyle Graumann, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 8600 Nicollet Ave S, Bloomington, MN 55420 Phone: 605-261-5044 | |
Paul Albert Berry, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8600 Nicollet Ave S, Mail Stop 31500a, Bloomington, MN 55420 Phone: 952-887-6600 Fax: 952-886-7015 |